Bispecific CAR T-cell Therapy Shows Early Promise for Relapsed or Refractory B-cell Lymphoma
PHILADELPHIA – Bispecific anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy was well tolerated and showed signs of clinical efficacy...
PHILADELPHIA – Bispecific anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy was well tolerated and showed signs of clinical efficacy...
PHILADELPHIA – Treatment with a modified herpesvirus in combination with radiation therapy was well tolerated and showed signs of...
PHILADELPHIA – Adding nivolumab (Opdivo) to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC)...
PHILADELPHIA – Pediatric patients with sporadic neuroblastoma harbored rare pathogenic variants in cancer predisposition genes that were inherited and...
PHILADELPHIA – Lower levels of cancer aneuploidy were associated with more favorable outcomes after immune checkpoint inhibition in patients...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
Study shows disruptions to cancer treatment could be minimized during the pandemic PHILADELPHIA – Compared with patients with cancer...
PHILADELPHIA – Among patients with lymphoma admitted to the hospital for severe COVID-19, those treated with B-cell-depleting therapies within...
PHILADELPHIA – Administering colorectal cancer screening kits through a socially distant drive-by flu vaccination clinic increased access to colorectal...
SAN ANTONIO – Early circulating tumor cell dynamics were associated with overall survival in patients with metastatic breast cancer,...